Skip to main content
. 2021 Sep 4;10(2):1467–1479. doi: 10.1007/s40122-021-00310-8

Table 5.

Changes of neurotransmitter concentrations in peripheral blood of 20 AS patients and ten healthy controls

PDQ > 19 (n = 6) PDQ ≤ 19 (n = 14) Control (n = 10) P
Sex (M/F) 4/2 13/1 8/2 0.3338
Age 42.67 ± 4.27 36.57 ± 2.72 0.21 ± 0.06 0.2394
Duration 18.67 ± 2.47 11.94 ± 2.19 0.0887
CRP 5.02 ± 2.60 8.09 ± 6.79 0.3028
BASDAI 4.27 ± 1.89 2.15 ± 1.17 0.0064**
NE 0.21 ± 0.06 0.13 ± 0.05 0.07 ± 0.02  < 0.001***
5HT 22.62 ± 9.65 20.50 ± 17.85 19.96 ± 10.01 0.9338
Gly 110.8 ± 21.37 96.61 ± 25.24 95.32 ± 34.52 0.5223
Glu 16.64 ± 7.32 29.83 ± 29.05 19.66 ± 5.05 0.3277
GABA 587.7 ± 19.01 629.0 ± 336.0 523.4 ± 135.4 0.6213
5HIAA 2.21 ± 0.97 3.97 ± 3.87 2.62 ± 0.67 0.3277
KYN 78.35 ± 25.35 83.87 ± 44.80 69.79 ± 18.05 0.4845
TRP 1,860 ± 402.7 2,067 ± 482.0 2,008 ± 446.7 0.6528

Data are expressed as the mean ± standard deviation (SD); P value represents comparison between the three groups, ***P < 0.001, **P < 0.01, *P < 0.05

CRP C-reactive protein, BASDAI bath assessment of ankylosing spondylitis disease activity index, NE norepinephrine, 5HT serotonin, Gly glycine, Glu glutamic acid, GABA γ-aminobutyric acid, 5HIAA 5-hydroxyindoleacetic acid, KYN kynurenine, TRP tryptophan